Advancing Precision Diagnostics in the Tumor Marker Testing Market
The Tumor Marker Testing Market is witnessing a transformative phase, driven by the escalating global incidence of cancer and the growing shift toward personalized medicine. As healthcare systems prioritize early diagnosis to improve survival rates, the demand for sophisticated diagnostic tools, including serum-based and tissue-based tumor markers, has surged. Advancements in molecular biology...
0 Comments 0 Shares 17 Views 0 Reviews